High-mobility group box-1 protein serum levels do not reflect monocytic function in patients with sepsis-induced immunosuppression

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Schefold, Joerg C ^a   Unterwalder, Nadine ^a   Meisel, Christian ^a   Savvatis, Konstantinos ^a   Hammoud, Ben ^a   Fotopoulou, Christina ^a   Volk, Hans Dieter ^a   Reinke, Petra ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HIGH MOBILITY GROUP B1 PROTEIN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD LEVEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME IMMUNOASSAY; EX VIVO STUDY; FEMALE; HIGH MOBILITY GROUP BOX DOMAIN; HUMAN; IMMUNE DEFICIENCY; IMMUNE STATUS; IMMUNOSTIMULATION; IN VIVO STUDY; INNATE IMMUNITY; LEUKOCYTE; LYMPHOCYTE; MALE; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; AGED; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; CYTOKINES; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HMGB1 PROTEIN; HUMANS; IMMUNE TOLERANCE; MALE; MIDDLE AGED; MONOCYTES; SEPSIS;

EID: 77955402483     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/745724     Document Type: Article

References (30)

1. Lotze M. T., Tracey K. J., High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal Nature Reviews Immunology 2005 5 4 331 342
2. Wang H., Zhu S., Zhou R., Li W., Sama A. E., Therapeutic potential of HMGB1-targeting agents in sepsis Expert Reviews in Molecular Medicine 2008 10 32 1 20
3. Mantell L. L., Parrish W. R., Ulloa L., HMGB-1 as a therapeutic target for infectious and inflammatory disorders Shock 2006 25 1 4 11
4. Ulloa L., Messmer D., High-mobility group box 1 (HMGB1) protein: friend and foe Cytokine and Growth Factor Reviews 2006 17 3 189 201
5. Wang H., Liao H., Ochani M., Justiniani M., Lin X., Yang L., Al-Abed Y., Wang H., Metz C., Miller E. J., Tracey K. J., Ulloa L., Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis Nature Medicine 2004 10 11 1216 1221
6. Bonaldi T., Talamo F., Scaffidi P., Ferrera D., Porto A., Bachi A., Rubartelli A., Agresti A., Bianchi M. E., Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion EMBO Journal 2003 22 20 5551 5560
7. Scaffidi P., Misteli T., Bianchi M. E., Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 2002 418 6894 191 195
8. Ivanov S., Dragoi A.-M., Wang X., Dallacosta C., Louten J., Musco G., Sitia G., Yap G. S., Wan Y., Biron C. A., Bianchi M. E., Wang H., Chu W.-M., A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA Blood 2007 110 6 1970 1981
9. Silva E., Arcaroli J., He Q., Svetkauskaite D., Coldren C., Nick J. A., Poch K., Park J. S., Banerjee A., Abraham E., HMGB1 and LPS induce distinct patterns of gene expression and activation in neutrophils from patients with sepsis-induced acute lung injury Intensive Care Medicine 2007 33 10 1829 1839
10. Tian J., Avalos A. M., Mao S.-Y., Chen B., Senthil K., Wu H., Parroche P., Drabic S., Golenbock D., Sirois C., Hua J., An L. L., Audoly L., La Rosa G., Bierhaus A., Naworth P., Marshak-Rothstein A., Crow M. K., Fitzgerald K. A., Latz E., Kiener P. A., Coyle A. J., Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE Nature Immunology 2007 8 5 487 496
11. Liu G., Wang J., Park Y. J., Tsuruta Y., Lorne E. F., Zhao X., Abraham E., High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine Journal of Immunology 2008 181 6 4240 4246
12. Sunden-Cullberg J., Norrby-Teglund A., Treutiger C. J., The role of high mobility group box-1 protein in severe sepsis Current Opinion in Infectious Diseases 2006 19 3 231 236
13. Treutiger C. J., Mullins G. E., Johansson A.-S. M., Rouhiainen A., Rauvala H. M. E., Erlandsson-Harris H., Andersson U., Yang H., Tracey K. J., Andersson J., Palmblad J. E. W., High mobility group 1 B-box mediates activation of human endothelium Journal of Internal Medicine 2003 254 4 375 385
14. Qin S., Wang H., Yuan R., Li H., Ochani M., Ochani K., Rosas-Ballina M., Czura C. J., Huston J. M., Miller E., Lin X., Sherry B., Kumar A., LaRosa G., Newman W., Tracey K. J., Yang H., Role of HMGB1 in apoptosis-mediated sepsis lethality Journal of Experimental Medicine 2006 203 7 1637 1642
15. Suda K., Kitagawa Y., Ozawa S., Saikawa Y., Ueda M., Ebina M., Yamada S., Hashimoto S., Fukata S., Abraham E., Maruyama I., Kitajima M., Ishizaka A., Anti-high-mobility group box chromosomal protein 1 antibodies improve survival of rats with sepsis World Journal of Surgery 2006 30 9 1755 1762
16. Annane P. D., Bellissant P. E., Cavaillon J.-M., Septic shock Lancet 2005 365 9453 63 78
17. Cohen J., The immunopathogenesis of sepsis Nature 2002 420 6917 885 891
18. Landelle C., Lepape A., Franais A., Tognet E., Thizy H., Voirin N., Timsit J. F., Monneret G., Vanhems P., Nosocomial infection after septic shock among intensive care unit patients Infection Control and Hospital Epidemiology 2008 29 11 1054 1065
19. Monneret G., Venet F., Pachot A., Lepape A., Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony Molecular Medicine 2008 14 1-2 64 78
20. Schefold J. C., Hasper D., Reinke P., Monneret G., Volk H. D., Consider delayed immunosuppression into the concept of sepsis Critical Care Medicine 2008 36 11, article 3118
21. Dcke W.-D., Randow F., Syrbe U., Krausch D., Asadullah K., Reinke P., Volk H.-D., Kox W., Monocyte deactivation in septic patients: restoration by IFN- treatment Nature Medicine 1997 3 6 678 681
22. Meisel C., Schefold J. C., Pschowski R., Baumann T., Hetzger K., Gregor J., Weber-Carstens S., Hasper D., Keh D., Zuckermann H., Reinke P., Volk H.-D., Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial American Journal of Respiratory and Critical Care Medicine 2009 180 7 640 648
23. Nierhaus A., Montag B., Timmler N., Frings D. P., Gutensohn K., Jung R., Schneider C. G., Pothmann W., Brassel A. K., Schulte Am Esch J., Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis Intensive Care Medicine 2003 29 4 646 651
24. Schefold J. C., von Haehling S., Corsepius M., Pohle C., Kruschke P., Zuckermann H., Volk H.-D., Reinke P., A novel selective extracorporeal intervention in sepsis: immunoadsorption of endotoxin, interleukin 6, and complement-activating product 5a Shock 2007 28 4 418 425
25. Schefold J. C., Hasper D., Volk H. D., Reinke P., Sepsis: time has come to focus on the later stages Medical Hypotheses 2008 71 2 203 208
26. Dcke W.-D., Hflich C., Davis K. A., Rttgers K., Meisel C., Kiefer P., Weber S. U., Hedwig-Geissing M., Kreuzfelder E., Tschentscher P., Nebe T., Engel A., Monneret G., Spittler A., Schmolke K., Reinke P., Volk H.-D., Kunz D., Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study Clinical Chemistry 2005 51 12 2341 2347
27. Knaus W. A., Draper E. A., Wagner D. P., Zimmerman J. E., APACHE II: a severity of disease classification system Critical Care Medicine 1985 13 10 818 829
28. Vincent J.-L., Moreno R., Takala J., Willatts S., De Mendona A., Bruining H., Reinhart C. K., Suter P. M., Thijs L. G., The SOFA (Sepsis-Related Organ Failure Assessment) score to describe organ dysfunction/failure Intensive Care Medicine 1996 22 7 707 710
29. Trapnell B. C., A novel biomarker-guided immunomodulatory approach for the therapy of sepsis American Journal of Respiratory and Critical Care Medicine 2009 180 7 585 586
30. Urbonaviciute V., Frnrohr B. G., Weber C., Haslbeck M., Wilhelm S., Herrmann M., Voll R. E., Factors masking HMGB1 in human serum and plasma Journal of Leukocyte Biology 2007 81 1 67 74